Dr. Randal S. Weber on Anti-EGFR Agents Showing Efficacy in Squamous Cell Carcinoma

Randal S. Weber, MD, FACS, head of the Department of Head and Neck Surgery, MD Anderson Cancer Center, discusses the importance of the epidermal growth factor receptor (EGFR) in squamous cell carcinoma (SCC). Weber says overactivity of these EGFR receptors may cause SCC tumors to become more aggressive. He adds that in a recent, small-scale study, effectively blocking the EGFR receptor in the tumor with anti-EGFR therapy proved to be successful.